PMT Biosciences

PMT Biosciences is a cross-border biopharmaceutical company advancing its therapeutic candidate, SYNAPTADINE, as a potential disease-modifying therapy for Parkinson’s disease. While current treatments primarily manage symptoms, PMT is focused on addressing the underlying biology driving disease progression.